Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New Poll: Trump Voters Want COVID Vaccine Information from Doctors, Not Politicians

Findings Reveal Language That Can Help Build Trust in Vaccines


News provided by

de Beaumont Foundation

Mar 25, 2021, 08:02 ET

Share this article

Share toX

Share this article

Share toX

BETHESDA, Md., March 25, 2021 /PRNewswire/ -- When deciding whether to get a COVID-19 vaccine, Republicans who voted for President Trump will be far more influenced by their doctors and family members than any politician, including Trump, according to a new national poll. When asked if they'd be more likely to get vaccinated if their doctor or Trump recommended it, 81% chose their doctor. This and other findings reveal that like other Americans, Trump voters see vaccination as a personal issue, not a political issue, and they want unbiased facts from doctors and other trusted, non-political sources.

A full 78% of all respondents said they may eventually get vaccinated. When asked if they would wait days, weeks, months, a year, or more than a year after it was available to them, 50% said they would wait months, and only 21% said more than a year.

Conducted by Frank Luntz on March 14-16 for the de Beaumont Foundation -- in partnership with United States of Care and Resolve to Save Lives, an initiative of Vital Strategies -- the poll identifies specific language that can help build confidence in the vaccines for all Americans. Findings include messages about the safety and effectiveness of the vaccines, the potential long-term effects of COVID-19, and the careful review process that each vaccine has followed. The poll findings, communication tips, and effective messaging are available at www.debeaumont.org/changing-the-covid-conversation/gopattitudes.

As previous polls of the general public have shown, Trump voters said they're most concerned about safety, the speed at which the vaccines were developed, and the unknown long-term side effects. These individuals found the following information helpful and said it made them more likely to take a vaccine:

  • The vaccines are up to 95% effective, even more than the annual flu vaccine, which is typically 40% to 60% effective.
  • If enough people are vaccinated, we can prevent 100,000 deaths or more.
  • Almost all doctors who have been offered the vaccine have taken it.
  • The speed of the vaccines' development was a result of cutting red tape and bureaucracy, not cutting corners or bypassing any safety precautions.
  • The phase 3 trials for the three authorized vaccines enrolled tens of thousands of people and none were hospitalized or died.

The poll questions were informed by a March 13 nationwide focus group with 19 Trump voters who said they may "possibly" get a COVID-19 vaccine or "probably would not." The poll validated many of the focus group findings, including a lack of trust of government, political leaders, and the media. "In both the focus group and the poll, they said they want to hear unbiased, un-politicized facts and data from doctors and medical professionals, not politicians," Luntz said.  "Then they want to make their own decisions. We heard very clearly they don't want to be told what to do by Washington, but they're open to listening to facts so they can make an informed decision."

Brian C. Castrucci, DrPH, president and CEO of the de Beaumont Foundation, said, "The poll findings make it clear that getting a COVID vaccine is a personal decision, and people want to keep politics out of it. The messaging we developed from these findings can help public health officials and others address the real concerns that Trump voters and many other Americans have."

Dr. Tom Frieden, MD, MPH, former director of the Centers for Disease Control and Prevention and current president of Resolve to Save Lives, said, "The messages and messengers matter when communicating the benefits of the COVID vaccine to people and communities across the United States and around the world. Transparency is key to vaccine rollout. It's important to share with people what we know when we know it, and be open about what we don't know and what we're doing to learn more."

Natalie Davis, co-founder of United States of Care, added, "We know that taking the vaccine is a personal medical decision and that people across populations need accurate information. When they get that honest and trusted information, they're deciding to get the vaccine. That's great news for all of us and shows just how important these conversations are."

The poll is the third in a series of national polls focused on "Changing the COVID Conversation,"  designed to guide more effective public health messaging during this pandemic among diverse populations, including Black Americans, Latinx communities, Republicans, rural residents, and others. For more details about the poll findings, visit www.debeaumont.org/changing-the-covid-conversation/gopattitudes.

Other Findings:

  • 96% said COVID-19 is real, but 55% think its risks have been exaggerated.
  • There are significant differences in the perceptions of older and younger Republicans. Those age 18-49 said they were almost equally concerned about getting COVID-19 (51%) as getting the vaccine (49%). But 69% of Republicans 50 and older said they were more concerned about the virus.
  • Respondents 18-49 said they would be more motivated than respondents 50+ by employee incentives, a day off, the recommendation of religious leaders, and the decision of friends and family members to get vaccinated.
  • 74% of all respondents said they always or usually wear masks when they are indoors and around others. At the same time, 70% said that no longer wearing masks was a compelling reason to get vaccinated.

Poll Methodology
The nationwide survey was conducted March 14-16 by pollster Frank Luntz, with 1,000 registered GOP voters who voted for President Trump in the 2020 election (+3% margin of error), modeled demographically based on voter turnout. They were polled about the specific words, sentences, phrases, and arguments that would make them more likely to take a COVID-19 vaccine.

About the de Beaumont Foundation
Founded in 1998, the de Beaumont Foundation creates and invests in bold solutions that improve the health of communities across the country. The Foundation advances policy, builds partnerships, and strengthens public health to create communities where people can achieve their best possible health. For more information, visit debeaumont.org.

About Frank Luntz
Frank I. Luntz, PhD, has written, supervised, and conducted more than 2,500 surveys, focus groups, ad tests, and dial sessions in more than two dozen countries and six continents over the past 35 years. He has worked for more than 50 Fortune 500 companies and CEOs, but he's best known for political commentary. More media outlets have turned to Dr. Luntz to understand the hopes and fears of Americans than to any other political pollster. For more information, visit filuntz.com.

Media Contact:
Mark Miller
(301) 802-6783   

SOURCE de Beaumont Foundation

Related Links

https://debeaumont.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.